C 57BU10 (BlO; H2 b ) mouse liver grafts are accepted in C3R (H2k) recipients without immunosuppressive tberapywhereas skin and heart grafts are rejected acutely.1 However, in vitro mixed leukocyte reactions (MLR) and the generation of cytotoxic T lymphocytes (crL) show the persistence of anti-donor responsiveness. 2 The mechanism underlying this "split tolerance" phenomenon is unclear. The present study was undertaken to test the hypothesis that split tolerance might be due to the elimination of effector CfL through apoptosis, while CfL precursors, unsusceptible to apoptosis persist, as shown by the MLR and CfL responses in vitro.
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MATERIALS AND METHODS
C3H recipients were sacrificed 4, 7. 14, and 60 days after BI0 liver transplantation. 3 Liver graft non-parenchymal cells (NPC) and splenocytes from the recipients were isolated for assay of crL activity by 51Cr release assay. 
RESULTS
Freshly isolated liver NPC exhibited high anti-donor CTL activity that peaked at postoperative day (POD) 4 (45% specific target cell lysis). declined to 37% at POD 7. to 12% at POD 14. then gradually dccreased to control level (5%). indicating that donor-specific CTL were induced initiallv and then eliminated shortly after liver transplantatio~.
Compared with NPC. freshly isolated recipient spleen cells showed much lower levels of cytotoxicity against donor targets ( 12% on POD 4). However. when thc spleen cells were cultured with donor spleen cells for 4 days, elevated levels of donor cell killing (431'} to 70%) were generated at all time points. indicating persistence of CTL precursors.
The fate of the CTL within liver graft NPC was investigated hy the detection uf apoptotic activity using hoth TUNEL and DNA fragmentation assays. Compared with isografts. numerous TUNEL-positive infiltratIng lymphocvtes were ohserved in the portal triads of liver allografts. <\poptotic activity peaked at POD 7 ;1I1d declined thereat-ter. In rejecting liver grafts (median survival time 5 d), there was a significantly lower incidence of apoptotic NPC, but extensive apoptosis of hepatocytes. Apoptosis was quantitated in freshly-isolated NPC by DNA fragmentation assay. Cells from accepted allografts showed much higher DNA fragmentation on POD 4 (34.8%), 7 (40.1%), and 14 (25.7%) compared with cells from isografts (12.6%, 14.5%, and 17.5%, respectively). NPC from rejecting allografts (IL-2 treatment) showed significantly lower DNA fragmentation (7.2% on POD 4), indicating that IL-2-induced rejection was associated with inhibition of infiltrating cell apoptosis. Two-color flow cytometric analysis of the NPC confirmed that augmented apoptosis of CD8+ T cells occurred within the allografted liver.
DISCUSSION
Allogeneic mouse liver transplantation without immunosuppression results in graft acceptance and donor-specific tolerance. l However. recipient T cells persistently exhibit MLR and CfL responses against donor alloantigens. 2 The transplanted grafts initially undergo a brief episode of rejection evidenced by graft infiltration that subsides within a few weeks. 2 Our data suggest that this is due to the programmed cell death of CTL. probably triggered hy interaction with donor antigen-presenting cells. Apoptosis of donor-reactive T cells may also occur in recipient lymphoid organs. hecause donor-derived antigen-presenting cells have heen shown to migrate to and persist in these sites after liver transplantation.1.7 Detection of apoptotic CTL in recipient lymphoid organs may not he as easy as within the graft due to the relatively low percentage of donor-reactive cells. Use of T cell receptor (TCR) transgenic mice. in which a large proportion of T cells express donor specific TCR. may shed additional light on mechanisms of liver transplant tolerance. re ut tily.
